An observational study in Patients Requiring Urgent Vascular Access, sponsored by Vidacare Corporation. Completed at 6 sites in United States. Per ClinicalTrials.gov, last updated 2025-12-15.
Sponsored by Vidacare Corporation · Observational
The purpose of this study is to evaluate the use of powered intraosseous vascular access (EZ-IO by Vidacare) in the emergency department for patients requiring urgent vascular access. Data collected will be compared to historical data on central venous catheter use in the emergency department. The primary hypothesis is that powered intraosseous vascular access will decrease the amount of time needed to obtain vascular access.
Vidacare Corporation is the lead sponsor of 13 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients requiring urgent vascular access
Exclusion Criteria:
subjects with urgent vascular access needs in whom intraosseous vascular access has been attempted and/or established.
Device: EZ-IO
powered intraosseous vascular access system
Also known as: EZ-IO by Vidacare, Powered intraosseous vascular access
Time to vascular access
Time from opening intraosseous device packaging to initial infusion of drugs or fluids via the intraosseous route.
Time frame: at time of patient's arrival to emergency department, average within 10 minutes
Incidence of complications with intraosseous device
Reported complications by intraosseous device operators.
Time frame: time subject has intraosseous vascular access, an average of 24 hours
This study is completed, as verified in Jun 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vidacare Corporation